Antimicrobial stewardship before and during the COVID-19 pandemic: A Possible Solution for Antimicrobial Resistance

Abstract: In the critical fight against antimicrobial resistance (AMR), Dr. Rasha Abdelsalam Elshenawy, a distinguished Clinical Pharmacist and PhD candidate at the University of Hertfordshire, leads an essential study on Antimicrobial Stewardship (AMS) during the COVID-19 pandemic. Recognized for her expertise in AMS, Dr. Elshenawy's research, featured during World Antimicrobial Awareness Week, examines the impact of the pandemic on AMS practices in acute care settings. With AMR causing over 1.2 million deaths in 2019 and antibiotic misuse on the rise, the study aims to inform and enhance AMS strategies, spotlighting the urgency of collaborative efforts. Supported by the University of Hertfordshire and aligned with the Sustainable Development Goals, Dr. Elshenawy's work is integral to promoting antibiotic awareness and developing robust responses to the global health crisis of AMR. Discover more about this pioneering research that navigates the complex challenges of AMR during unprecedented times, fostering a culture of responsible antibiotic use and stewardship in healthcare. Keywords: Antimicrobial Resistance, COVID-19, Antimicrobial Stewardship, Global Health, Sustainable Development Goals, Antibiotic Use, Healthcare Collaboration, Academic Research, AMS Implementation, Public Health Education, NHS Foundation Trust, University of Hertfordshire, World Antimicrobial Awareness Week, Clinical Pharmacy, Infection Control, Pandemic Response, AMR Deaths, Antibiotic Misuse, Healthcare Policy, World Antibiotic Awareness Week.